KRAS and cancer: Although some of these cell lines were found to be susceptible to TRAIL-induced apoptosis, there is no clear correlation between TRAIL sensitivity and the status of K-Ras or H-Ras mutations in the NCI60 panel of human cancer cell lines (Table 1).